Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-012273
Filing Date
2019-04-22
Accepted
2019-04-22 16:37:25
Documents
3
Period of Report
2019-06-06
Effectiveness Date
2019-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A rcus-def14a_20190606.htm DEF 14A 752871
2 GRAPHIC gw42wez1pdx3000001.jpg GRAPHIC 74360
3 GRAPHIC gw42wez1pdx3000002.jpg GRAPHIC 64450
  Complete submission text file 0001564590-19-012273.txt   945324
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38419 | Film No.: 19759773
SIC: 2834 Pharmaceutical Preparations